These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10822766)

  • 41. Complete mammary necrosis due to acenocoumarol.
    Pérez-Guarinos CV; García-García ML; Verdú-Fernández Mde L; Aguayo-Albasini JL
    Cir Esp; 2015; 93(7):472. PubMed ID: 26026907
    [No Abstract]   [Full Text] [Related]  

  • 42. Disseminated intravascular coagulation in cancer patients.
    Levi M
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):129-36. PubMed ID: 19285279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pure red cell aplasia followed by disseminated intravascular coagulation in a haemodialysis patient receiving erythropoietin-beta.
    Manenti L; Vaglio A
    Nephrol Dial Transplant; 2007 May; 22(5):1465-7. PubMed ID: 17337465
    [No Abstract]   [Full Text] [Related]  

  • 44. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Patient education for patients treated with anticoagulants. Nursing care, a relationship voyage].
    Pilloud D
    Krankenpfl Soins Infirm; 2002; 95(11):56-9. PubMed ID: 12510430
    [No Abstract]   [Full Text] [Related]  

  • 47. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.
    Visser LE; Penning-van Beest FJ; Wilson JH; Vulto AG; Kasbergen AA; De Smet PA; Hofman A; Stricker BH
    Br J Clin Pharmacol; 2004 Apr; 57(4):522-4. PubMed ID: 15025752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
    Penning-van Beest FJ; Koerselman J; Herings RM
    J Thromb Haemost; 2008 Feb; 6(2):284-90. PubMed ID: 18031295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Jaundice associated with acenocoumarol exposure.
    de Bruyne EL; Jan Bac D; de Man RA; Dees A
    Neth J Med; 1998 May; 52(5):187-9. PubMed ID: 9652157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prolonged fever following treatment with acenocoumarol].
    Renou C; Malaterre HR; Bernardini D; Castellani P; Botta-Fridlund D; Gauthier A
    Rev Med Interne; 1996; 17(1):93-4. PubMed ID: 8677395
    [No Abstract]   [Full Text] [Related]  

  • 51. [Long-term treatment with low molecular weight heparin, of chronic disseminated intravascular coagulation].
    García Fernández JR; López Berenguel F; Ais C
    An Med Interna; 2003 Apr; 20(4):191-4. PubMed ID: 12768833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute disseminated intravascular coagulation developed during menstruation in an adenomyosis patient.
    Nakamura Y; Kawamura N; Ishiko O; Ogita S
    Arch Gynecol Obstet; 2002 Dec; 267(2):110-2. PubMed ID: 12439560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acenocoumarol associated priapism: report of a case.
    Touloupidis S; Zoumpos I; Kalaitzis C; Vogiatzaki T; Chloropoulou P
    Andrologia; 2004 Feb; 36(1):47-9. PubMed ID: 14871265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug Interaction between Acenocoumarol and Linezolid.
    Ghosh K; Ghosh K
    J Assoc Physicians India; 2017 Sep; 65(9):107. PubMed ID: 29313591
    [No Abstract]   [Full Text] [Related]  

  • 55. Understanding low INR in clinical practice.
    Hylek EM; Rose AJ
    Thromb Haemost; 2009 Mar; 101(3):417-8. PubMed ID: 19277399
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pharmacological interaction of glucosamine sulphate and acenocoumarol].
    Garrote García M; Iglesias Piñeiro MJ; Martín Alvarez R; Pérez González J
    Aten Primaria; 2004 Feb; 33(3):162-3. PubMed ID: 14987502
    [No Abstract]   [Full Text] [Related]  

  • 57. Acenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of.
    Wenstedt EFE; Huysentruyt CJ; Konings CJAM
    Neth J Med; 2017 May; 75(4):161-164. PubMed ID: 28522774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis, diagnosis, and management of disseminated intravascular coagulation: a literature review.
    Dalainas I
    Eur Rev Med Pharmacol Sci; 2008; 12(1):19-31. PubMed ID: 18401969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.